APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Uricase

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Uricase Market Analysis and Forecast 2026-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchRecombinant Uricase Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Uricase Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Recombinant Uricase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Uricase Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Uricase Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Recombinant Uricase market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Uricase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Uricase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Uricase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Uricase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Uricase include Horizo​​n Therapeutics and Sanofi etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Uricase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Uricase, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Uricase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Uricase sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Uricase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Uricase sales, projected growth trends, production technology, application and end-user industry.

Recombinant Uricase Segment by Company

Horizo​​n Therapeutics

Sanofi

Recombinant Uricase Segment by Type

Rasburicase

Pegloticase

Other

Recombinant Uricase Segment by Application

Gout

Kidney Stones

Cancer

Other

Recombinant Uricase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Uricase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Uricase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Uricase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Uricase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Uricase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Uricase sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Uricase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rasburicase Major Manufacturers Table 3. Pegloticase Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Recombinant Uricase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gout Major Manufacturers Table 7. Kidney Stones Major Manufacturers Table 8. Cancer Major Manufacturers Table 9. Other Major Manufacturers Table 10. Recombinant Uricase Industry Trends Table 11. Recombinant Uricase Industry Drivers Table 12. Recombinant Uricase Industry Opportunities and Challenges Table 13. Recombinant Uricase Industry Restraints Table 14. Global Recombinant Uricase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Recombinant Uricase Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Recombinant Uricase Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Recombinant Uricase Revenue Market Share by Region (2021-2026) Table 18. Global Recombinant Uricase Revenue Market Share by Region (2027-2032) Table 19. Global Recombinant Uricase Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Recombinant Uricase Sales by Region (2021-2026) & (K Units) Table 21. Global Recombinant Uricase Sales by Region (2027-2032) & (K Units) Table 22. Global Recombinant Uricase Sales Market Share by Region (2021-2026) Table 23. Global Recombinant Uricase Sales Market Share by Region (2027-2032) Table 24. Global Recombinant Uricase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Recombinant Uricase Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Recombinant Uricase Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Recombinant Uricase Sales Market Share by Manufacturers (2021-2026) Table 28. Global Recombinant Uricase Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Recombinant Uricase Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Recombinant Uricase Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Recombinant Uricase Manufacturers, Product Type & Application Table 32. Global Recombinant Uricase Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Recombinant Uricase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Recombinant Uricase Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Recombinant Uricase Revenue Market Share by Type (2021-2026) Table 39. Global Recombinant Uricase Revenue Market Share by Type (2027-2032) Table 40. Global Recombinant Uricase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 42. Global Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 43. Global Recombinant Uricase Sales Market Share by Type (2021-2026) Table 44. Global Recombinant Uricase Sales Market Share by Type (2027-2032) Table 45. Global Recombinant Uricase Price by Type (2021-2026) & (US$/Unit) Table 46. Global Recombinant Uricase Price by Type (2027-2032) & (US$/Unit) Table 47. Global Recombinant Uricase Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Recombinant Uricase Revenue Market Share by Application (2021-2026) Table 51. Global Recombinant Uricase Revenue Market Share by Application (2027-2032) Table 52. Global Recombinant Uricase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 54. Global Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 55. Global Recombinant Uricase Sales Market Share by Application (2021-2026) Table 56. Global Recombinant Uricase Sales Market Share by Application (2027-2032) Table 57. Global Recombinant Uricase Price by Application (2021-2026) & (US$/Unit) Table 58. Global Recombinant Uricase Price by Application (2027-2032) & (US$/Unit) Table 59. Horizo​​n Therapeutics Company Information Table 60. Horizo​​n Therapeutics Business Overview Table 61. Horizo​​n Therapeutics Recombinant Uricase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Horizo​​n Therapeutics Recombinant Uricase Product Portfolio Table 63. Horizo​​n Therapeutics Recent Development Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Recombinant Uricase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Recombinant Uricase Product Portfolio Table 68. Sanofi Recent Development Table 69. North America Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 72. North America Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 73. North America Recombinant Uricase Sales Price by Type (2021-2026) & (US$/Unit) Table 74. North America Recombinant Uricase Sales Price by Type (2027-2032) & (US$/Unit) Table 75. North America Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 76. North America Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 77. North America Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 78. North America Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 79. North America Recombinant Uricase Sales Price by Application (2021-2026) & (US$/Unit) Table 80. North America Recombinant Uricase Sales Price by Application (2027-2032) & (US$/Unit) Table 81. North America Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Recombinant Uricase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 83. North America Recombinant Uricase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 84. North America Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 85. North America Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 86. North America Recombinant Uricase Sales by Country (2027-2032) & (K Units) Table 87. North America Recombinant Uricase Sales Price by Country (2021-2026) & (US$/Unit) Table 88. North America Recombinant Uricase Sales Price by Country (2027-2032) & (US$/Unit) Table 89. United States Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 90. Canada Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 91. Mexico Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 92. Europe Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 95. Europe Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 96. Europe Recombinant Uricase Sales Price by Type (2021-2026) & (US$/Unit) Table 97. Europe Recombinant Uricase Sales Price by Type (2027-2032) & (US$/Unit) Table 98. Europe Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 101. Europe Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 102. Europe Recombinant Uricase Sales Price by Application (2021-2026) & (US$/Unit) Table 103. Europe Recombinant Uricase Sales Price by Application (2027-2032) & (US$/Unit) Table 104. Europe Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Recombinant Uricase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. Europe Recombinant Uricase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. Europe Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 108. Europe Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 109. Europe Recombinant Uricase Sales by Country (2027-2032) & (K Units) Table 110. Europe Recombinant Uricase Sales Price by Country (2021-2026) & (US$/Unit) Table 111. Europe Recombinant Uricase Sales Price by Country (2027-2032) & (US$/Unit) Table 112. Germany Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 113. France Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 114. U.K. Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 115. Italy Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 116. Russia Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 117. Spain Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 118. Netherlands Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 119. Switzerland Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 120. Sweden Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 121. Poland Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 122. China Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 123. China Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 124. China Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 125. China Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 126. China Recombinant Uricase Sales Price by Type (2021-2026) & (US$/Unit) Table 127. China Recombinant Uricase Sales Price by Type (2027-2032) & (US$/Unit) Table 128. China Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 129. China Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 130. China Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 131. China Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 132. China Recombinant Uricase Sales Price by Application (2021-2026) & (US$/Unit) Table 133. China Recombinant Uricase Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Asia Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 137. Asia Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 138. Asia Recombinant Uricase Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Asia Recombinant Uricase Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Asia Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 143. Asia Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 144. Asia Recombinant Uricase Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Asia Recombinant Uricase Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Recombinant Uricase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Asia Recombinant Uricase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Asia Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Asia Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 151. Asia Recombinant Uricase Sales by Country (2027-2032) & (K Units) Table 152. Asia Recombinant Uricase Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Asia Recombinant Uricase Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Japan Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 155. South Korea Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 156. India Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 157. Australia Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 158. Taiwan Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 159. Southeast Asia Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 160. SAMEA Recombinant Uricase Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Recombinant Uricase Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 163. SAMEA Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 164. SAMEA Recombinant Uricase Sales Price by Type (2021-2026) & (US$/Unit) Table 165. SAMEA Recombinant Uricase Sales Price by Type (2027-2032) & (US$/Unit) Table 166. SAMEA Recombinant Uricase Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Recombinant Uricase Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 169. SAMEA Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 170. SAMEA Recombinant Uricase Sales Price by Application (2021-2026) & (US$/Unit) Table 171. SAMEA Recombinant Uricase Sales Price by Application (2027-2032) & (US$/Unit) Table 172. SAMEA Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Recombinant Uricase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. SAMEA Recombinant Uricase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. SAMEA Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. SAMEA Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 177. SAMEA Recombinant Uricase Sales by Country (2027-2032) & (K Units) Table 178. SAMEA Recombinant Uricase Sales Price by Country (2021-2026) & (US$/Unit) Table 179. SAMEA Recombinant Uricase Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Brazil Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 181. Argentina Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 182. Chile Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 183. Colombia Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 184. Peru Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 185. Saudi Arabia Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 186. Israel Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 187. UAE Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 188. Turkey Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 189. Iran Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 190. Egypt Recombinant Uricase Revenue (2021-2032) & (US$ Million) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Recombinant Uricase Distributors List Table 194. Recombinant Uricase Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Recombinant Uricase Image Figure 2. Global Recombinant Uricase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Uricase Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rasburicase Image Figure 5. Pegloticase Image Figure 6. Other Image Figure 7. Global Recombinant Uricase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Recombinant Uricase Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gout Image Figure 10. Kidney Stones Image Figure 11. Cancer Image Figure 12. Other Image Figure 13. Global Recombinant Uricase Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Recombinant Uricase Revenue (2021-2032) & (US$ Million) Figure 15. Global Recombinant Uricase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Recombinant Uricase Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Recombinant Uricase Revenue Market Share by Region (2021-2032) Figure 18. Global Recombinant Uricase Sales (2021-2032) & (K Units) Figure 19. Global Recombinant Uricase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Recombinant Uricase Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Recombinant Uricase Sales YoY (2021-2032) & (K Units) Figure 22. Europe Recombinant Uricase Sales YoY (2021-2032) & (K Units) Figure 23. China Recombinant Uricase Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Recombinant Uricase Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Recombinant Uricase Sales YoY (2021-2032) & (K Units) Figure 26. Global Recombinant Uricase Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Recombinant Uricase Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Recombinant Uricase Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Recombinant Uricase Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Recombinant Uricase Revenue Market Share by Type (2021-2032) Figure 32. Global Recombinant Uricase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Recombinant Uricase Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Recombinant Uricase Sales Market Share by Type (2021-2032) Figure 35. Global Recombinant Uricase Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Recombinant Uricase Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Recombinant Uricase Revenue Market Share by Application (2021-2032) Figure 38. Global Recombinant Uricase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Recombinant Uricase Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Recombinant Uricase Sales Market Share by Application (2021-2032) Figure 41. North America Recombinant Uricase Revenue Share by Type (2021-2032) Figure 42. North America Recombinant Uricase Sales Share by Type (2021-2032) Figure 43. North America Recombinant Uricase Revenue Share by Application (2021-2032) Figure 44. North America Recombinant Uricase Sales Share by Application (2021-2032) Figure 45. North America Recombinant Uricase Revenue Share by Country (2021-2032) Figure 46. North America Recombinant Uricase Sales Share by Country (2021-2032) Figure 47. Europe Recombinant Uricase Revenue Share by Type (2021-2032) Figure 48. Europe Recombinant Uricase Sales Share by Type (2021-2032) Figure 49. Europe Recombinant Uricase Revenue Share by Application (2021-2032) Figure 50. Europe Recombinant Uricase Sales Share by Application (2021-2032) Figure 51. Europe Recombinant Uricase Revenue Share by Country (2021-2032) Figure 52. Europe Recombinant Uricase Sales Share by Country (2021-2032) Figure 53. China Recombinant Uricase Revenue Share by Type (2021-2032) Figure 54. China Recombinant Uricase Sales Share by Type (2021-2032) Figure 55. China Recombinant Uricase Revenue Share by Application (2021-2032) Figure 56. China Recombinant Uricase Sales Share by Application (2021-2032) Figure 57. Asia Recombinant Uricase Revenue Share by Type (2021-2032) Figure 58. Asia Recombinant Uricase Sales Share by Type (2021-2032) Figure 59. Asia Recombinant Uricase Revenue Share by Application (2021-2032) Figure 60. Asia Recombinant Uricase Sales Share by Application (2021-2032) Figure 61. Asia Recombinant Uricase Revenue Share by Country (2021-2032) Figure 62. Asia Recombinant Uricase Sales Share by Country (2021-2032) Figure 63. SAMEA Recombinant Uricase Revenue Share by Type (2021-2032) Figure 64. SAMEA Recombinant Uricase Sales Share by Type (2021-2032) Figure 65. SAMEA Recombinant Uricase Revenue Share by Application (2021-2032) Figure 66. SAMEA Recombinant Uricase Sales Share by Application (2021-2032) Figure 67. SAMEA Recombinant Uricase Revenue Share by Country (2021-2032) Figure 68. SAMEA Recombinant Uricase Sales Share by Country (2021-2032) Figure 69. Recombinant Uricase Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Recombinant Uricase Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Rasburicase
  • Pegloticase
  • Other
Applications
  • Gout
  • Kidney Stones
  • Cancer
  • Other
Companies covered
  • Horizo​​n Therapeutics
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Uricase Market by Type
  3. 1.2.1 Global Recombinant Uricase Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rasburicase
  5. 1.2.3 Pegloticase
  6. 1.2.4 Other
  7. 1.3 Recombinant Uricase Market by Application
  8. 1.3.1 Global Recombinant Uricase Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gout
  10. 1.3.3 Kidney Stones
  11. 1.3.4 Cancer
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Recombinant Uricase Market Dynamics
  1. 2.1 Recombinant Uricase Industry Trends
  2. 2.2 Recombinant Uricase Industry Drivers
  3. 2.3 Recombinant Uricase Industry Opportunities and Challenges
  4. 2.4 Recombinant Uricase Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Uricase Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Uricase Revenue by Region
  3. 3.2.1 Global Recombinant Uricase Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Uricase Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Uricase Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Uricase Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Uricase Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Uricase Sales by Region
  9. 3.4.1 Global Recombinant Uricase Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Uricase Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Uricase Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Uricase Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Uricase Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Uricase Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Uricase Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Uricase Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Uricase Sales by Manufacturers
  6. 4.2.1 Global Recombinant Uricase Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Uricase Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Uricase Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Uricase Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Uricase Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Uricase Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Uricase Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Uricase Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Uricase Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Uricase Tier 1, Tier 2, and Tier 3
5 Recombinant Uricase Market by Type
  1. 5.1 Global Recombinant Uricase Revenue by Type
  2. 5.1.1 Global Recombinant Uricase Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Uricase Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Uricase Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Uricase Sales by Type
  6. 5.2.1 Global Recombinant Uricase Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Uricase Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant Uricase Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Uricase Price by Type
6 Recombinant Uricase Market by Application
  1. 6.1 Global Recombinant Uricase Revenue by Application
  2. 6.1.1 Global Recombinant Uricase Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Uricase Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Uricase Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Uricase Sales by Application
  6. 6.2.1 Global Recombinant Uricase Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Uricase Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant Uricase Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Uricase Price by Application
7 Company Profiles
  1. 7.1 Horizo​​n Therapeutics
  2. 7.1.1 Horizo​​n Therapeutics Company Information
  3. 7.1.2 Horizo​​n Therapeutics Business Overview
  4. 7.1.3 Horizo​​n Therapeutics Recombinant Uricase Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Horizo​​n Therapeutics Recombinant Uricase Product Portfolio
  6. 7.1.5 Horizo​​n Therapeutics Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Recombinant Uricase Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Recombinant Uricase Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Recombinant Uricase Market Size by Type
  2. 8.1.1 North America Recombinant Uricase Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Uricase Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Uricase Price by Type (2021-2032)
  5. 8.2 North America Recombinant Uricase Market Size by Application
  6. 8.2.1 North America Recombinant Uricase Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Uricase Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Uricase Price by Application (2021-2032)
  9. 8.3 North America Recombinant Uricase Market Size by Country
  10. 8.3.1 North America Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Uricase Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Uricase Market Size by Type
  2. 9.1.1 Europe Recombinant Uricase Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Uricase Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Uricase Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Uricase Market Size by Application
  6. 9.2.1 Europe Recombinant Uricase Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Uricase Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Uricase Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Uricase Market Size by Country
  10. 9.3.1 Europe Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Uricase Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Uricase Market Size by Type
  2. 10.1.1 China Recombinant Uricase Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Uricase Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Uricase Price by Type (2021-2032)
  5. 10.2 China Recombinant Uricase Market Size by Application
  6. 10.2.1 China Recombinant Uricase Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Uricase Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Uricase Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Uricase Market Size by Type
  2. 11.1.1 Asia Recombinant Uricase Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Uricase Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Uricase Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Uricase Market Size by Application
  6. 11.2.1 Asia Recombinant Uricase Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Uricase Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Uricase Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Uricase Market Size by Country
  10. 11.3.1 Asia Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Uricase Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Uricase Market Size by Type
  2. 12.1.1 SAMEA Recombinant Uricase Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Uricase Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Uricase Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Uricase Market Size by Application
  6. 12.2.1 SAMEA Recombinant Uricase Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Uricase Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Uricase Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Uricase Market Size by Country
  10. 12.3.1 SAMEA Recombinant Uricase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Uricase Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Uricase Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Uricase Value Chain Analysis
  2. 13.1.1 Recombinant Uricase Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Uricase Production Mode & Process
  6. 13.2 Recombinant Uricase Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Uricase Distributors
  9. 13.2.3 Recombinant Uricase Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst